| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $424.24 | $3,393,884.39 | -45.9% | +20.0% | - | |
| Sep 29, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $58.79 | $155,029.23 | -1.6% | -42.3% | - | |
| Sep 29, 2025 | CGC Canopy Growth Corp | Atkins M Shan51 | Director | Sell | 2,216 | $1.58 | $3,501.28 | -4.9% | -22.9% | - | |
| Sep 29, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 85,000 | $60.20 | $5,116,923.50 | -54.8% | -42.3% | - | |
| Sep 29, 2025 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 15,677 | $1.58 | $24,769.66 | -13.2% | -22.9% | - | |
| Sep 29, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael | President And COO | Sell | 22,500 | $421.80 | $9,490,511.91 | -16.8% | +18.5% | - | |
| Sep 29, 2025 | CGC Canopy Growth Corp | Kruh Willy74 | Director | Sell | 10,451 | $1.58 | $16,512.58 | -14.2% | -22.9% | - | |
| Sep 29, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 42,000 | $38.33 | $1,609,860.00 | -54.9% | +5.7% | - | |
| Sep 29, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 10,235 | $48.02 | $491,484.70 | -0.9% | +7.7% | - | |
| Sep 29, 2025 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 10,408 | $1.58 | $16,444.64 | -12.3% | -22.9% | - | |
| Sep 29, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 60,000 | $0.23 | $13,506.00 | -0.6% | - | - | |
| Sep 26, 2025 | AQST Aquestive Therapeutics, Inc. | Boyd Peter E.81 | See Remarks | Sell | 10,000 | $6.30 | $63,000.00 | -3.5% | 0.0% | - | |
| Sep 26, 2025 | AQST Aquestive Therapeutics, Inc. | Barber Daniel72 | President And CEO | Sell | 91,343 | $6.03 | $551,191.06 | -9.0% | 0.0% | - | |
| Sep 26, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A | Chairperson &CEO | Sell | 8,000 | $429.58 | $3,436,630.00 | -46.9% | +17.2% | - | |
| Sep 24, 2025 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 1,000 | $440.00 | $440,000.00 | -17.1% | +16.3% | - | |
| Sep 24, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $426.14 | $3,409,081.18 | -71.4% | +16.3% | - | |
| Sep 24, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 2,100 | $56.52 | $118,692.00 | -0.7% | -34.6% | - | |
| Sep 23, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 29,513 | $47.23 | $1,393,898.99 | -2.5% | +10.0% | - | |
| Sep 22, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 23,584 | $57.74 | $1,361,766.10 | -18.3% | -39.3% | - | |
| Sep 22, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $416.35 | $9,367,953.75 | -100% | +23.9% | - | |
| Sep 22, 2025 | CGC Canopy Growth Corp | Mongeau Luc79 | Chief Executive Officer | Buy | 27,469 | $1.82 | $49,993.58 | +3.5% | 0.0% | - | |
| Sep 22, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 16,587 | $47.02 | $779,920.74 | -1.5% | +9.6% | - | |
| Sep 22, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $414.19 | $3,313,522.60 | -77.0% | +23.9% | - | |
| Sep 19, 2025 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 1,800 | $415.43 | $747,767.88 | -26.3% | +21.4% | - | |
| Sep 19, 2025 | AQST Aquestive Therapeutics, Inc. | Barber Daniel72 | President And CEO | Sell | 400 | $6.00 | $2,400.00 | - | +2.5% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.